Article PDF
Abbreviations
- CSII:
-
Continuous Subcutaneous insulin infusion
- IDDM:
-
insulin-dependent diabetes mellitus
- AGE:
-
advanced glycation end products
- DCCT:
-
Diabetes Control and Complications Trial
References
Dahl-JØrgensen K (1987) Near-normoglycemia and late diabetic complications. The Oslo Study (Thesis). Acta Endocrinol (Copenh) 115 [Suppl 284]: 1–56
Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T and the Steno Study group (1985) Two year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 35 [Suppl 3]: 74–79
Feldt-Rasmussen B, Mathiesen ER, Deckert T (1986) Effect of 2 years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet I: 1300–1304
Beck-Nielsen H, Richelsen B, Mogensen CE, Olsen T, Ehlers N, Nielsen CB et al. (1985) Effect of insulin pump treatment for 1 year on renal function and retinal morphology in patients with IDDM. Diabetes Care 8: 585–589
Dahl-JØrgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E et al. (1986) Effect of near-normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy and neuropathy, the Oslo Study. BMJ 293: 1195–1199
Hanssen KF, Bangstad H-J, Brinchmann-Hansen O, Dahl-JØrgensen K (1992) Blood glucose control and diabetic microvascular complications — long term effects of near-normoglycemia. Diabet Med 9: 697–705
Hanssen KF, Dahl-JØrgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986) Diabetic control and microvascular complications — the near-normoglycemic experience. Diabetologia 29: 677–684
Reichard P, Nilsson B-Y, Rosenqvist U (1993) The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med 329: 304–309
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977–986
Johnsson S (1960) Retinopathy and nephropathy in diabetes mellitus: comparison of the effects of two forms of treatment. Diabetes 9: 1–8
Pirart T (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188
Klein R, Klein BEK, Moss SE, Cruickshanks KJ (1993) Glycosylated hemoglobin predicts the 10-year progression of diabetic retinopathy. Diabetes 42 [Suppl 1] 29A (Abstract)
Doft BH, Kingsley LA, Orchard TF, Kuller L, Drash A, Becker D (1984) The association between long-term diabetic control and early retinopathy. Ophthalmology 91: 763–769
Weber B, Burger W, Hartmann R, Hövener G, Malchus R, Oberdisse U (1986) Risk factors for the development of retinopathy in children and adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 29: 23–29
Wiseman M, Viberti GC, Mackintosh D, Jarrett RF, Keen H (1984) Glycaemia, arterial pressure and microalbuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 26: 401–405
Bangstad H-J, Hanssen KF, Dahl-JØrgensen K, AagenÆs Ø (1989) Microalbuminuria is associated with long term poor glycemic control in adolescent insulin dependent diabetics. Diabetes Res 12: 71–74
Mortensen HB, Martinelli K, NØrgaard K, Main K, Kastrup KW, Ibsen KK et al. (1990) A nation-wide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type 1 diabetes mellitus. Diabet Med 7: 887–897
Joner G, Brinchmann-Hansen O, Torres CG, Hanssen KF (1992) A nationwide cross-sectional study of retinopathy and microalbuminuria in young Norwegian type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 1049–1054
Keen H (1984) Normoglycemia re-entry and diabetic complications. Diabet Med 1: 85–87
KROC Collaborative Study Group (1988) Diabetic retinopathy after two years of intensified insulin treatment. JAMA 260: 37–41
Dahl-JØrgensen K, Brinchmann-Hansen O, Hanssen KF, Sandvik L, AagenÆs Ø (1985) Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus. The Oslo Study. BMJ 290: 811–815
CNR Study Group on Diabetic Retinopathy (1989) The effect of continuous insulin infusion as compared with conventional insulin therapy in the evolution of diabetic retinal ischemia — two years report. Diab Nutri Metab 3: 165–174
Reichard P, Berglund B, Britz A, Cars I, Nilsson BT, Rosenqvist U (1991) Intensified conventional insulin treatment retards the microvascular complications of insulin dependent diabetes mellitus (IDDM): The Stockholm Diabetes Intervention Study after five years. J Int Med 230: 101–108
Rosenlund E, Haakens K, Brinchmann-Hansen O, Dahl-JØrgensen K, Hanssen KF (1988) Transient proliferative retinopathy during intensified insulin treatment. Am J Ophthalmol 105: 618–625
Brinchmann-Hansen O, Dahl-JØrgensen K, Sandvik L, Hanssen KF (1992) Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo Study. BMJ 304: 19–22
Dahl-JØrgensen K, Hanssen KF, Kierulf P, BjØro T, Sandvik L, AagenÆs Ø (1988) Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. Acta Endocrinol (Copenh) 117: 19–25
Dahl-JØrgensen K, BjØro T, Kierulf P, Sandvik L, Bangstad H-J, Hanssen KF (1992) Long term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int 41: 920–923
Amthor KF, Dahl-JØrgensen K, Berg TJ, Hanssen KF, Skard Heier M, Sandvik L, AagenÆs Ø (1994) The effect of eight years of strict glycaemic control on peripheral nerve function in insulin-dependent diabetes mellitus. The Oslo Study. Diabetologia 37: 579–584
Feldt-Rasmussen B, Mathiesen ER, Jensen T, Lauritzen T, Deckert T (1991) Effect of improved metabolic control on loss of kidney function in insulin-dependent diabetic patients. Diabetologia 34: 164–170
Wang PH, Lau J, Chalmers TC (1993) Meta-analysis of effects of intensive blood-glucose control on late complications of type-1 diabetes. Lancet 341: 1306–1309
Bangstad H-J, Dahl-JØrgensen K, Hartmann A, Hanssen KF (1994) Improvement of blood glucose control retards the progression of morphological changes in early diabetic nephropathy. Diabetologia 37: 483–490
Bucala R, Cerami A (1992) Advanced glycosylation: chemistry, biology, and implications for diabetes and aging. Adv Pharmacol 23: 1–34
UK Prospective Diabetes Study Group (1991) UK Prospective Diabetes Study VIII: study design, progress and performance. Diabetologia 34: 877–890
Goldstein DE, Blinder KJ, Ide CH et al. (1993) Glycemic control and development of retinopathy in youth-onset insulin-dependent diabetes mellitus. Ophthalmology 10; 30: 1–8
Bolli G, De Feo P, Compagnucci P et al. (1983) Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32: 134–141
Bolli GB, Fanelli C, Epifano L et al. (1993) Reversibility of hypoglycaemia unawareness in type 1 diabetes mellitus: the one year report. Diabetologia 36 [Suppl 1]: A37 (Abstract)
Beaufort CE de, Bruining GJ (1987) Continuous subcutaneous insulin infusion in children. Diabet Med 4: 103–108
Brink SJ, Stewart C (1986) Insulin pump treatment in insulin-dependent diabetes mellitus. JAMA 5; 225: 617–621
Author information
Authors and Affiliations
Additional information
This review was written in connection with the Camillo Golgi lecture given by Kristian F. Hanssen in receipt of the Castello Pedroli Prize at the EASD Annual Meeting in Istanbul, Turkey, September 1993.
Rights and permissions
About this article
Cite this article
Dahl-JØrgensen, K., Brinchmann-Hansen, O., Bangstad, HJ. et al. Blood glucose control and microvascular complications — what do we do now?. Diabetologia 37, 1172–1177 (1994). https://doi.org/10.1007/BF00399789
Issue Date:
DOI: https://doi.org/10.1007/BF00399789